HealthProves
Home/Manufacturers/Chain Drug Consortium, LLC
Manufacturer profile

Chain Drug Consortium, LLC

Pharmaceutical company2 products tracked
2
products tracked
48,108
total reports
64
recalls on record
67.6%
serious overall
Products
showing 2 of 2
ProductApprovedReports ↓Top signalRecalls
—46,895Pemphigus64
—1,213Vulvovaginal burning sensation0
Recall history · 50 on record
DateClassReasonFirm
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
May 28, 2026IIPresence of foreign substance: small metallic particles in chewable tablets.Guardian Drug Co. Inc.
Dec 19, 2025IIFailed Disintegration Specifications: above the time expected.Sato Pharmaceutical Co., Ltd
Dec 2, 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
Dec 2, 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
Dec 2, 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
Dec 2, 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
Dec 2, 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
Dec 2, 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
Dec 2, 2022IIPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC
Jun 23, 2022IICGMP Deviations: product held outside appropriate storage temperature conditions.Family Dollar Stores, Llc.
Jan 26, 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
Jan 26, 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
Jan 26, 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
Jan 26, 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
Jan 26, 2022IICGMP DeviationsULTRAtab Laboratories, Inc.
Jan 24, 2022IIcGMP deviationsUltra Seal Corporation
Jan 24, 2022IIcGMP deviationsUltra Seal Corporation
May 28, 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
May 28, 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
May 28, 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
May 28, 2020IILabeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.Glaxosmithkline Consumer Healthcare Holdings
Nov 6, 2018IIPresence of foreign substance: Product found to contain metal particles.L. Perrigo Company
May 7, 2018IICGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.RIJ Pharmaceutical LLC
May 7, 2018IICGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.RIJ Pharmaceutical LLC
Mar 30, 2017IIDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc.
Mar 30, 2017IIDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc.
Mar 30, 2017IIDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc.
Apr 16, 2015IIProducts failed the Antimicrobial Effectiveness Test.Tarmac Products, Inc.

Class I = reasonable probability of serious harm · Class II = temporary or reversible · Class III = unlikely to cause harm.

Registration status

Some products from Chain Drug Consortium, LLC are not FDA-registered for human use. For unregistered substances (peptides, SARMs without human registration), no legitimate human-use supplier exists. The absence of a sourcing route is the safety information.